254 related articles for article (PubMed ID: 20981286)
1. Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.
Masuo K
Int J Hypertens; 2010 Oct; 2010():832821. PubMed ID: 20981286
[TBL] [Abstract][Full Text] [Related]
2. Adrenoceptor Polymorphisms in Hypertension and Diabetes with obesity-update in 2014.
Masuo K
Curr Hypertens Rev; 2014 Aug; ():. PubMed ID: 25115695
[TBL] [Abstract][Full Text] [Related]
3. Relationships of adrenoceptor polymorphisms with obesity.
Masuo K; Lambert GW
J Obes; 2011; 2011():609485. PubMed ID: 21603275
[TBL] [Abstract][Full Text] [Related]
4. Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Jul; 18(7):1009-14. PubMed ID: 16054001
[TBL] [Abstract][Full Text] [Related]
5. beta2- and beta3-Adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals.
Kawaguchi H; Masuo K; Katsuya T; Sugimoto K; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2006 Dec; 29(12):951-9. PubMed ID: 17378367
[TBL] [Abstract][Full Text] [Related]
6. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.
Masuo K; Rakugi H; Ogihara T; Esler MD; Lambert GW
Curr Diabetes Rev; 2010 Mar; 6(2):58-67. PubMed ID: 20034369
[TBL] [Abstract][Full Text] [Related]
8. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
9. Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through beta1- and putative beta4-adrenoceptors in mouse left atria: no evidence for beta2- and beta3-adrenoreceptor function.
Oostendorp J; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):134-45. PubMed ID: 10685868
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptor polymorphism in human cardiovascular disease.
Leineweber K
Ann Med; 2004; 36 Suppl 1():64-9. PubMed ID: 15176426
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for differences between cardiac atypical beta-adrenoceptors and brown adipose tissue beta3-adrenoceptors in the pithed rat.
Malinowska B; Schlicker E
Br J Pharmacol; 1997 Dec; 122(7):1307-14. PubMed ID: 9421276
[TBL] [Abstract][Full Text] [Related]
12. Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population.
Pereira AC; Floriano MS; Mota GF; Cunha RS; Herkenhoff FL; Mill JG; Krieger JE
Hypertension; 2003 Oct; 42(4):685-92. PubMed ID: 12900437
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor polymorphisms.
Leineweber K; Büscher R; Bruck H; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):1-22. PubMed ID: 14647973
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes.
Leineweber K; Brodde OE
Life Sci; 2004 Apr; 74(23):2803-14. PubMed ID: 15072081
[TBL] [Abstract][Full Text] [Related]
15. The peripheral sympathetic nervous system in human obesity.
van Baak MA
Obes Rev; 2001 Feb; 2(1):3-14. PubMed ID: 12119635
[TBL] [Abstract][Full Text] [Related]
16. Role of β
Leblanc C; Tabrizchi R
Eur J Pharmacol; 2018 Jan; 819():136-143. PubMed ID: 29208473
[TBL] [Abstract][Full Text] [Related]
17. High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals.
Masuo K; Katsuya T; Sugimoto K; Kawaguchi H; Rakugi H; Ogihara T; Tuck ML
Hypertens Res; 2007 Jun; 30(6):503-11. PubMed ID: 17664853
[TBL] [Abstract][Full Text] [Related]
18. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor.
Masuo K; Katsuya T; Kawaguchi H; Fu Y; Rakugi H; Ogihara T; Tuck ML
Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290
[TBL] [Abstract][Full Text] [Related]
19. Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
Horinouchi T; Koike K
J Auton Pharmacol; 2000 Aug; 20(4):253-8. PubMed ID: 11260363
[TBL] [Abstract][Full Text] [Related]
20. The genetic polymorphisms of beta3-adrenergic receptor (AR) Trp64Arg and beta2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients.
Mo W; Zhang GG; Yang TL; Dai XP; Li HH; Zeng H; Liu J; Tan YM; Zhou HH; Liu ZQ
Clin Chem Lab Med; 2007; 45(4):493-8. PubMed ID: 17439327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
